UC San Diego Health is among 31 health facilities selected from across the state to participate in the California Bridge Program, an accelerated, 18-month training program for health care providers to enhance access to around-the-clock treatment for patients with opioid use disorder.
Mining a large database of adverse reactions to medications, UC San Diego researchers found that people who took proton pump inhibitors (e.g., Prilosec, Nexium) for heartburn and acid reflux were more likely to experience kidney disease than people who took other forms of antacid.
The Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center.
Researchers at UC San Diego School of Medicine report that persons with schizophrenia scored lower on a wisdom assessment than non-psychiatric comparison participants, but that there was considerable variability in levels of wisdom, and those with higher scores displayed fewer psychotic symptoms.
In a randomized, controlled pilot trial published February 13, 2019 in PLOS ONE, UC San Diego School of Medicine researchers found that participants pre-treated with noninvasive vagus nerve stimulation experienced less pain after heat stimulus than mock-treated participants.
By examining how mammary cells respond in a stiffness-changing hydrogel, researchers discovered that several pathways work together to signal breast cells to turn cancerous. The work could inspire new approaches to treating patients and inhibiting tumor growth.
In a new study, researchers at University of California San Diego School of Medicine report that hearing impairment is associated with accelerated cognitive decline with age, though the impact of mild hearing loss may be lessened by higher education.
Using HIV genetic data, researchers discovered that transgender women in Los Angeles are at higher risk of being in an HIV transmission network than men who have sex with men. In addition, cisgender men in these clusters should be considered at higher risk for HIV than previously thought.
UC San Diego will host its 9th annual Center for Circadian Biology Symposium Feb. 13-15, 2019. The three-day event, entitled “From Cells to Clinic,” will culminate with a talk from the winner of the 2017 Nobel Prize in Medicine Michael W. Young, who will speak about delayed phase sleep disorders.
The Adult Congenital Heart Disease Program at UC San Diego Health is the only one in the region to provide a multi-disciplinary team with extensive knowledge in congenital heart disease and help patients transition from pediatric care to adult care.